HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsuko Yuzawa Selected Research

pegaptanib (Macugen)

9/2014[Japan phase 3 study of pegaptanib sodium in patients with diabetic macular edema].
9/2013[Comparison of 1-year treatment outcome of intravitreal pegaptanib sodium versus bevacizumab for myopic choroidal neovascularization].
4/2013[Intravitreal pegaptanib sodium for myopic choroidal neovascularization: 1 year results of a prospective pilot study].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitsuko Yuzawa Research Topics

Disease

23Macular Degeneration (Age-Related Maculopathy)
01/2020 - 01/2002
21Polypoidal Choroidal Vasculopathy
06/2018 - 07/2003
17Choroidal Neovascularization
03/2018 - 02/2002
11Central Serous Chorioretinopathy
01/2021 - 04/2011
7Retinal Detachment (Retinal Detachments)
06/2018 - 01/2009
5Hemorrhage
06/2018 - 07/2008
4Endophthalmitis (Ophthalmia)
06/2015 - 12/2008
3Cicatrix (Scar)
03/2018 - 06/2003
3Cataract (Cataracts)
08/2017 - 01/2011
3Diabetic Retinopathy (Retinopathy, Diabetic)
09/2015 - 05/2010
3Macular Edema
09/2014 - 06/2009
3Atrophy
11/2005 - 07/2003
2Polyps
01/2018 - 04/2013
2Vision Disorders (Hemeralopia)
05/2014 - 04/2013
2Prodromal Symptoms
12/2012 - 12/2008
2Hypoxia (Hypoxemia)
11/2008 - 02/2007
1Hypertension (High Blood Pressure)
01/2022
1Retinal Drusen
01/2022
1Disease Susceptibility (Diathesis)
11/2018
1Fibrosis (Cirrhosis)
03/2018
1Vitreous Hemorrhage
09/2015
1Infections
04/2014
1Papilledema
07/2010
1Telangiectasis (Telangiectasia)
07/2010
1Microaneurysm
07/2010
1Retinal Perforations
06/2010
1Rupture
08/2009
1Epiretinal Membrane (Epiretinal Membranes)
07/2009
1Vitreous Detachment (Posterior Vitreous Detachment)
06/2009
1Retinal Artery Occlusion
12/2007
1Retinal Neovascularization
02/2007
1Body Weight (Weight, Body)
06/2006
1Low Vision (Subnormal Vision)
04/2004
1Acquired Immunodeficiency Syndrome (AIDS)
04/2004
1Angioid Streaks
06/2003

Drug/Important Bio-Agent (IBA)

19Retinaldehyde (Retinal)IBA
01/2022 - 10/2003
171-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2017 - 05/2006
12Indocyanine Green (Cardio-Green)FDA LinkGeneric
03/2018 - 02/2002
10Verteporfin (Visudyne)FDA Link
01/2018 - 09/2006
7Ranibizumab (Lucentis)FDA Link
10/2018 - 04/2013
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2015 - 02/2007
5Povidone-Iodine (Betadine)FDA LinkGeneric
08/2017 - 01/2011
5Bevacizumab (Avastin)FDA Link
09/2015 - 03/2008
4Fluorescein (Funduscein)FDA LinkGeneric
03/2018 - 07/2008
3afliberceptIBA
01/2017 - 01/2015
3pegaptanib (Macugen)FDA Link
09/2014 - 04/2013
2SaltsIBA
08/2017 - 06/2015
2SolutionsIBA
08/2017 - 06/2015
2Complement Factor H (Factor H)IBA
09/2011 - 01/2011
1Large Neutral Amino Acid-Transporter 1IBA
11/2018
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
03/2018
1Interleukin-6 (Interleukin 6)IBA
03/2018
1Small Interfering RNA (siRNA)IBA
03/2018
1Polyvinyl AlcoholIBA
08/2017
1IodineIBA
08/2017
1AntioxidantsIBA
01/2017
1N-acetyltryptophanamide (NATA)IBA
01/2017
1LuteinIBA
01/2017
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2016
1salicylhydroxamic acid (SHAM)IBA
09/2015
1Anti-Bacterial Agents (Antibiotics)IBA
06/2015
1glutathione-bicarbonate-Ringer solution (BSS plus)FDA LinkGeneric
06/2015
1Protein Isoforms (Isoforms)IBA
02/2015
1Complement Factor B (Factor B)IBA
06/2014
1Complement C2 (Complement Component 2)IBA
06/2014
1Pharmaceutical PreparationsIBA
12/2012
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
01/2011
1ElastinIBA
01/2011
1perflutren (octafluoropropane)FDA Link
06/2010
1Capsules (Microcapsules)IBA
08/2009
1coomassie Brilliant BlueIBA
07/2009
1Retinal Pigments (Pigments, Visual)IBA
12/2008
1TESIBA
12/2007
1von Willebrand FactorIBA
02/2007
1S 10 (S-10)IBA
06/2006

Therapy/Procedure

20Photochemotherapy (Photodynamic Therapy)
01/2021 - 06/2006
10Vitrectomy
01/2016 - 01/2002
7Therapeutics
10/2018 - 09/2006
7Intravitreal Injections
01/2017 - 04/2013
5Light Coagulation
06/2009 - 10/2002
4Lasers (Laser)
01/2009 - 10/2002
3Injections
01/2018 - 04/2013
3Aftercare (After-Treatment)
04/2013 - 05/2008
2Retreatment
06/2018 - 07/2010
1Surgical Instruments (Clip)
08/2017
1Scleral Buckling
04/2014
1Diet Therapy (Therapy, Diet)
12/2012
1Transjugular Intrahepatic Portasystemic Shunt
09/2012
1Cannula
06/2010
1Anesthesia
08/2009
1Phacoemulsification
08/2009
1Laser In Situ Keratomileusis (LASIK)
01/2009
1Intravenous Injections
06/2006